Accelerated hypofractionated breast radiotherapy with simultaneous integrated boost: a feasibility study
Budhi Singh Yadav, Shipra Gupta, Divya Dahiya, Ankita Gupta, Arun Singh Oinam
Radiat Oncol J. 2022;40(2):127-140. Published online 2022 Jun 20 DOI: https://doi.org/10.3857/roj.2021.01053
Citations to this article as recorded by 
Is FAST FORWARD the Way Forward in Radiotherapy for Locally Advanced Breast Cancer – Learnings From the COVID Pandemic
Prashanth Giridhar, Satyajit Pradhan, Lincoln Pujari, Prarabdh Singh, Abhishek Shinghal, Chaturbhaj Khandelwal, Chandrima Mukherjee, Mayank Tripathi, Varun Shukla, Manikandan M. V., Zacchariah Choudary, Anuj Gupta
Clinical Breast Cancer.2024; 24(3): e116. CrossRef
HYPofractionated Adjuvant RadioTherapy in 1 versus 2 weeks in high-risk patients with breast cancer (HYPART): a non-inferiority, open-label, phase III randomised trial
Budhi Singh Yadav, Divya Dahiya, P. Kannan, Shikha Goyal, Ishita Laroiya, Santhosh Irrinki, Ngangom Robert Singh, Reena Sharma
Trials.2024;[Epub] CrossRef
Preliminary results of hypofractionated radiotherapy in breast cancer in Chandigarh, India: single-centre, non-inferiority, open-label, randomised, phase 3 trial
Budhi Singh Yadav, Divya Dahiya, Manish Gupta, Ankita Gupta, Arun S. Oinam, Siddhant Khare, Santhosh Irrinki, Ngangom Robert, Yashwant Raj Sakaray, Satish S. Nagaraj, Reena Kumari
The Lancet Regional Health - Southeast Asia.2024; 24: 100392. CrossRef
Hypofractionation for Regional Nodal Irradiation in Breast Cancer: Best of Both the Worlds
Budhi Singh Yadav, Treshita Dey
Clinical Breast Cancer.2024;[Epub] CrossRef